Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03322865
Title Obinutuzumab in Marginal Zone Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Christian Buske
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU


No variant requirements are available.